ArticleAmerican journal of translational research2023
Establishment and application of severity assessment system for patients with delayed encephalopathy caused by carbon monoxide poisoning.
Article in American journal of translational research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 citations in OpenAlex.
- Predictors of delayed encephalopathy after acute carbon monoxide poisoning: a literature review.Frontiers in medicine · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo identify the factors related to the severity of delayed encephalopathy after acute carbon monoxide poisoning (DEACMP) and establishment of a clinical nomogram assessment model.
methodsClinical data of 200 patients with DEACMP admitted to the First Hospital of Yulin from January 2019 to December 2022 were retrospectively analyzed. The patients were classified into severe and non-severe groups according to the severity of the disease. Clinical data was collected from both groups. Logistic regression was applied to analyze the risk factors for disease severity of DEACMP patients. The risk prediction model of the nomogram was constructed by incorporating risk factors, and its effectiveness was verified. Model differentiation performance was evaluated using the Respondent Operating Characteristic (ROC) Curve. Model calibration curve was adopted for fitting the situation of evaluation. The consistency of the model was evaluated by Hosmer-Lemeshow (H-L) analysis.
resultAge, coma time out of exposure, creatine kinase (CK), caspase, and red blood cell distribution width (RDW) were the risk factors for the severe DEACMP. A nomogram prediction model was built based on the above indicators. The area under the curve (AUC) of the model in predicting severe DEACMP was 0.961 (95% CI: 0.934-0.988) and 0.929 (95% CI: 0.841-1) in the training and test sets, respectively. The H-L test showed good goodness of fit (χ
conclusionAge, coma time out of exposure, CK, caspase, and RDW were significantly correlated with the severity of DEACMP patients. The nomogram prediction model incorporating the five indicators has certain clinical reference value for predicting the severe DEACMP and could be used as an accurate and rapid clinical assessment tool.
Indexed as
Identifiers
38074832PMC10703643W4389803187What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.